Patents by Inventor H. Donlon Skerrett

H. Donlon Skerrett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DRUG DELIVERY AND IMAGING CHEMICAL CONJUGATE, FORMULATIONS AND METHODS OF USE THEREOF
    Publication number: 20210277016
    Abstract: The present invention relates to compounds, and methods of use thereof, capable of entering macrophages. The invention further relates to compounds capable of modulating (for example inhibiting) the activity of the mammalian target of rapamycin (mTor), treating mTor-associated diseases, in particular, but not limited to, related to mTor in macrophages. The invention also relates to compounds capable of imaging mTor in a subject, in particular, but not limited to, mTor in macrophages.
    Type: Application
    Filed: May 26, 2021
    Publication date: September 9, 2021
    Inventors: Steven Jay Adelman, H. Donlon Skerrett, William A. Kinney
  • Drug delivery and imaging chemical conjugate, formulations and methods of use thereof
    Patent number: 11034701
    Abstract: The present invention relates to compounds of Formula 1, and methods of use thereof, capable of entering macrophages. The invention further relates to compounds capable of modulating (for example inhibiting) the activity of the mammalian target of rapamycin (mTor), treating mTor-associated diseases, in particular, but not limited to, related to mTor in macrophages. The invention also relates to compounds capable of imaging mTor in a subject, in particular, but not limited to, mTor in macrophages.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: June 15, 2021
    Assignee: NANOPHAGIX LLC
    Inventors: Steven Jay Adelman, H. Donlon Skerrett, William A. Kinney
  • DRUG DELIVERY AND IMAGING CHEMICAL CONJUGATE, FORMULATIONS AND METHODS OF USE THEREOF
    Publication number: 20180162869
    Abstract: The present invention relates to compounds, and methods of use thereof, capable of entering macrophages. The invention further relates to compounds capable of modulating (for example inhibiting) the activity of the mammalian target of rapamycin (mTor), treating mTor-associated diseases, in particular, but not limited to, related to mTor in macrophages. The invention also relates to compounds capable of imaging mTor in a subject, in particular, but not limited to, mTor in macrophages.
    Type: Application
    Filed: June 15, 2016
    Publication date: June 14, 2018
    Inventors: Steven Jay Adelman, H. Donlon Skerrett, William A. Kinney
  • METHODS FOR IMAGING VASCULAR INFLAMMATION USING IMPROVED NANOPARTICLE CONTRAST AGENTS
    Publication number: 20110311457
    Abstract: The present invention also provides methods and compositions for imaging and evaluating, e.g., blood flow or inflammation in a subject. Such evaluations are important in a number of clinical diagnoses, including assessing organ damage associated with angina pectoris, heart attack, stroke, cancer, atherosclerosis, and the like, as well as assessing vessel leakages associated with aneurisms, diffuse bleedings after trauma, and the like.
    Type: Application
    Filed: July 28, 2008
    Publication date: December 22, 2011
    Applicant: NANOSCAN IMAGING, LLC
    Inventors: H. Donlon Skerrett, Joseph Patterson, Robert W. Lee, Zahi A. Fayad